BETHESDA, Md., Dec. 8, 2015 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced the results of its Board of Directors election, including newly elected members to the Executive Committee. PDA members voted for new members to the Executive Committee and for directors this past fall.
The Chair-Elect is Rebecca Devine, a regulatory consultant and former official with the U.S. FDA. Rebecca will serve for two years as the Chair-Elect before becoming Chair in 2018. Current Chair-Elect Martin VanTrieste, Amgen, Inc., becomes the Chair for 2016 and 2017, and current Chair Hal Baseman, ValSource, will serve two additional years on the Executive Committee as Immediate Past Chair.
Michael Sadowski, Baxter Healthcare, was elected Treasurer, and Jette Christensen, Novo Nordisk A/S was elected Secretary. Both will serve two years in these roles.
Rejoining the Board of Directors for a second consecutive three-year term is Stephan Roenninger, Amgen.
Joining the Board of Directors for a three-year term are:
Anil Sawant, Merck & Co., Inc.
Susan Schniepp, Regulatory Compliance Associates, Inc.
Melissa Seymour, Biogen
PDA also thanks Board members whose terms of service have concluded:
Anders Vinther, Sanofi Pasteur (outgoing Immediate Past Chair)
Gabriele Gori, GSK Vaccines
Lisa Skeens, Pfizer
Ian Elvins, Elvins & Associates
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; email@example.com
SOURCE Parenteral Drug Association